Teva Generics:
Who We Are

As a leading provider of generic drugs, Teva Pharmaceuticals understands the importance of making safe, quality medications accessible - and affordable. 

In the United States, Teva markets over 500 generic prescription products in more than 1,500 dosage strengths, packaging sizes and forms, including oral solid dosage forms, injectable products, inhaled products, transdermal patches, and topical formulations. 02 With a leadership position (top 3) in 25 markets around the world 03, the scale and breadth of our generics portfolio has a significant impact on global healthcare.

Did you know that, in the United States, 300 million generic prescriptions per year are filled with a Teva product? 01 Teva generics saved the U.S. healthcare system an estimated $375 billion over the last decade, and nearly $29 billion in 2020. Additionally, Teva employs nearly 6,100 employees in the United States and operates in 11 states and Puerto Rico. 02 Learn about how Teva positively impacts economies in the U.S. and around the world.

Teva Pharmaceuticals, Inc. and its US affiliates are subsidiaries of Teva Pharmaceutical Industries Ltd., headquartered in Israel, a global leader in generics. Learn more about our history and how we have grown to be a leading provider of generic drugs.

Choosing Teva Generics is choosing to enjoy the benefits Teva can provide.

References

1. Back to contents.

   IMS Health NPA Data as of MAT Dec 2021.

2. Back to contents.

   Internal Data on File. Teva Economic Impact Report - July 2021.

3. Back to contents.

   Internal Data on File.